- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02016144
Optimal Length of Pre-inserted ETT for Nasal Fiber Optic Intubation
December 14, 2013 updated by: Jung-Man Lee, Seoul National Uinversity Dental Hospital
Optimal Length of the Pre-inserted Endotracheal Tube for Obtaining Good View of Laryngeal Opening for Nasal Fibreoptic Intubation
This study is intended to find the optimal length of pre-inserted ETT for nasal fiberoptic intubation and the equation to predict it.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-768
- Seoul National University Dental Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients scheduled to undergo an elective oral and maxillofacial surgery requiring a nasal intubation of ETT for general anesthesia
Description
Inclusion Criteria:
- ASA physical status I-II
- aged 20-65 yr (adults)
Exclusion Criteria:
- rhinitis
- bleeding diatheses
- requirement of awake intubation
- a previous major oral and maxillofacial surgery history
- anatomical deformity of the face, neck and upper airway
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
optimal length of pre-inserted ETT for nasal fiberoptic intubation
Time Frame: during endotracheal intubation for general anesthesia
|
during endotracheal intubation for general anesthesia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jung-Man Lee, M.D, Seoul National Uinversity Dental Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
December 14, 2013
First Submitted That Met QC Criteria
December 14, 2013
First Posted (Estimate)
December 19, 2013
Study Record Updates
Last Update Posted (Estimate)
December 19, 2013
Last Update Submitted That Met QC Criteria
December 14, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- JLee_optimal_length
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nasal Fiberoptic Intubation
-
Kaohsiung Medical University Chung-Ho Memorial...UnknownAwake Fiberoptic Nasal IntubationTaiwan
-
Kocaeli City HospitalNot yet recruitingVideolaryngoscopy | Awake Fiberoptic Nasal Intubation | Awake Endotracheal Intubation | Airway Management Assessment | Supraglottic Airway Device InsertionTurkey (Türkiye)
-
Second Military Medical UniversityCompletedTransillumination-guided Fiberoptic Intubation IntubationChina
-
Zagazig UniversityCompletedAwake Fiberoptic IntubationEgypt
-
Kasr El Aini HospitalCompletedFiberoptic Tracheal Intubation
-
Zagazig UniversityCompletedAwake Fiberoptic IntubationEgypt
-
Hospira, now a wholly owned subsidiary of PfizerCompletedAwake Fiberoptic IntubationUnited States
-
American University of Beirut Medical CenterCompleted
-
Johannes Gutenberg University MainzCompletedAwake Fiberoptic IntubationGermany
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedFiberoptic Intubation in ChildrenUnited States